Poly Medicure Ltd

Poly Medicure Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Poly Medicure Ltd

₹ 1,202 -2.26%
30 Mar 1:23 p.m.
polymedicure.com BSE: 531768 NSE: POLYMED
About

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

Key Points

Product Portfolio
It is a medical devices company with a product portfolio comprised of 200+ SKUs of medical devices across 12 specialties including therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. [1]

Website BSE NSE
  • Market Cap ₹ 12,183 Cr.
  • Current Price ₹ 1,202
  • High / Low ₹ 2,938 / 1,191
  • Stock P/E 35.1
  • Book Value ₹ 285
  • Dividend Yield 0.29 %
  • ROCE 18.2 %
  • ROE 14.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 26.5% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE 500 BSE Healthcare Nifty 500 BSE Allcap BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
272 293 306 320 321 361 367 402 411 421 384 417 419
203 212 220 237 236 264 266 290 295 305 283 305 307
Operating Profit 68 82 85 83 84 97 101 113 115 116 101 111 112
OPM % 25% 28% 28% 26% 26% 27% 28% 28% 28% 28% 26% 27% 27%
14 9 13 13 17 16 17 27 22 24 42 34 23
Interest 5 2 2 2 3 3 3 3 3 2 3 3 4
Depreciation 14 15 15 15 16 16 19 20 21 21 23 24 25
Profit before tax 64 73 81 78 82 94 96 117 113 116 117 118 106
Tax % 26% 22% 25% 24% 25% 25% 25% 25% 25% 26% 25% 25% 26%
48 57 61 59 61 71 72 87 85 87 88 89 78
EPS in Rs 4.96 5.99 6.31 6.17 6.41 7.35 7.53 8.61 8.40 8.55 8.68 8.79 7.73
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
312 373 393 439 507 586 646 746 879 1,068 1,306 1,601 1,640
238 288 307 345 386 452 483 536 665 801 954 1,153 1,200
Operating Profit 74 85 86 94 122 134 162 210 214 266 352 448 441
OPM % 24% 23% 22% 21% 24% 23% 25% 28% 24% 25% 27% 28% 27%
11 28 8 13 14 16 19 19 39 36 57 89 122
Interest 9 10 10 8 11 13 20 10 5 10 13 14 12
Depreciation 14 18 20 23 28 36 39 46 53 56 62 81 93
Profit before tax 62 84 65 76 96 100 122 173 195 237 335 443 458
Tax % 31% 27% 27% 26% 27% 34% 24% 25% 25% 24% 25% 25%
43 61 47 56 70 66 92 130 146 179 252 331 342
EPS in Rs 4.88 6.92 5.36 6.37 7.96 7.51 10.47 13.51 15.23 18.66 26.23 32.70 33.75
Dividend Payout % 20% 18% 28% 39% 25% 27% 19% 19% 16% 16% 11% 11%
Compounded Sales Growth
10 Years: 16%
5 Years: 20%
3 Years: 22%
TTM: 6%
Compounded Profit Growth
10 Years: 21%
5 Years: 26%
3 Years: 31%
TTM: 10%
Stock Price CAGR
10 Years: 24%
5 Years: 8%
3 Years: 9%
1 Year: -45%
Return on Equity
10 Years: 17%
5 Years: 15%
3 Years: 15%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 22 22 22 44 44 44 44 48 48 48 48 51 51
Reserves 122 170 202 225 290 336 385 906 1,029 1,186 1,410 2,694 2,838
67 76 79 97 127 150 194 126 111 137 164 172 226
71 87 73 83 93 103 117 107 146 167 199 224 282
Total Liabilities 282 354 376 449 555 633 740 1,187 1,334 1,538 1,821 3,140 3,396
120 161 177 201 260 272 328 389 451 598 831 1,047 1,158
CWIP 20 10 14 20 18 19 25 21 43 78 71 93 83
Investments 6 6 6 6 18 42 58 385 384 181 221 1,127 1,147
137 178 180 222 258 300 330 392 456 681 699 873 1,008
Total Assets 282 354 376 449 555 633 740 1,187 1,334 1,538 1,821 3,140 3,396

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
65 63 62 55 76 113 127 116 126 197 256 237
-58 -57 -30 -54 -87 -104 -106 -434 -89 -189 -237 -1,191
6 -9 -31 -1 14 -10 -22 319 -40 -8 -17 953
Net Cash Flow 13 -2 1 0 3 -1 -1 1 -2 -0 2 -2
Free Cash Flow 7 15 30 0 -6 68 23 23 -24 -40 -13 -87
CFO/OP 112% 102% 88% 78% 81% 105% 100% 76% 81% 96% 94% 73%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 53 58 75 79 81 77 68 73 80 76 72 78
Inventory Days 140 146 105 193 207 138 241 202 210 222 194 215
Days Payable 102 103 77 136 130 93 144 104 109 95 89 66
Cash Conversion Cycle 91 101 103 136 157 123 165 171 181 203 177 226
Working Capital Days 19 24 36 58 74 58 45 73 80 65 52 73
ROCE % 33% 30% 26% 25% 26% 23% 25% 21% 16% 19% 22% 18%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Countries Exported To
Count

Log in to view insights

Please log in to see hidden values.

Login
Number of SKUs / Product Categories
Count
Patents Granted (Cumulative)
Count
Domestic Revenue Contribution
%
R&D Expenditure (Percentage of Turnover)
%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
53.32% 53.32% 53.17% 53.17% 53.14% 66.02% 62.56% 62.44% 62.44% 62.44% 62.42% 62.42%
16.21% 15.61% 14.49% 14.10% 12.37% 9.91% 11.88% 12.33% 11.46% 11.41% 9.77% 9.41%
3.67% 4.25% 5.15% 5.46% 7.21% 9.34% 12.33% 11.66% 11.96% 11.72% 13.53% 13.84%
26.79% 26.82% 27.20% 27.28% 27.25% 14.72% 13.23% 13.57% 14.13% 14.43% 14.28% 14.34%
No. of Shareholders 35,39336,14134,64936,05336,71236,85238,35260,68665,58371,14264,40067,750

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls